12:00 AM
Jan 05, 2009
 |  BC Week In Review  |  Company News  |  Deals

ArQule, Daiichi Sankyo, Roche deal

ArQule and Daiichi signed their previously announced deal to co-develop and co-market ArQule's ARQ 197 to treat cancer (see BioCentury, Nov. 17, 2008).


Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >